Keynote Thomas Gajewski
One of the keynote speakers of this years' NVVI Annual Meeting is Thomas Gajewski. The focus of Dr. Gajewski’s work has been on understanding fundamental aspects of anti-tumor immunity and bringing these concepts forward from the laboratory into clinical trial testing in patients.
Recent work has identified germline polymorphisms and evidence for commensal microbiota that also regulate anti-tumor immunity, suggesting additional novel ways to facilitate improved cancer immunotherapy outcomes.
Title of his keynote lecture at our NVVI Annual Meeting is: 'Mechanism-based development of cancer immunotherapies'